• SENSEX 78,009.25
    -70.71 (--0.09%)
  • BANKNIFTY 57,491.10
    -144.15 (--0.25%)
  • ICICI Pru Life
    511.95 706.50(%)
  • HDFC Bank
    729.65 1,020.35(%)
  • Apollo Hospitals
    8,925.00 9,326.80(%)
  • Wework India
    700.00 419.60(%)
  • LG Electronics
    1,736.35 1,736.40(%)
  • Gland Pharma
    3,039.00 3,039.00(%)
  • Bharti Airtel
    2,005.65 2,174.70(%)
  • Leap India
    143.10 143.10(%)
  • Blue Star
    1,497.00 1,450.00(%)
  • Cupid
    288.00 32.76(%)
  • Netweb Technol.
    4,995.00 2,037.65(%)
  • Honasa Consumer
    509.90 509.90(%)
  • Manorama Indust.
    1,867.00 1,867.00(%)
  • Vodafone Idea
    14.17 15.35(%)
  • Technocraft Ven.
    334.60 334.60(%)
  • Bharat Dynamics
    1,420.00 1,655.25(%)
  • Dixon Technolog.
    14,210.00 18,471.50(%)
  • Billionbrains
    194.60 112.02(%)
  • Infosys
    1,159.00 984.00(%)
  • Gujarat Fluoroch
    4,897.00 4,959.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aarti Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Aarti Group
  • BSE Code : 2975.0
  • ISIN : INE767A01016
416.35 -11 (-2.65%)
  • As on 15 Aug 2026 (EOD)

  • Today’s Low

    414.10

  • Today’s High

    430.00

  • Open

    429.00

  • Perv Close

    427.70

  • 52W Low

    318.95

  • 52W High

    534.55

Key Indicators

  • P/E(TTM)

    22.01

  • Mar.Cap (₹Cr.)

    3,800.03

  • Div & Yield %

    0.48

  • Book Value(₹)

    153.92

  • Debt-Equity Ratio

    -2.65

  • AGM Date

    14-Aug-2026

  • EPS

    18.95

  • P/E Ratio

    22.01

Financials Ratios

  • Debt-Equity Ratio

    0.47

  • Mar.Cap (₹Cr.)

    3,800.03

  • RONW (%)

    13.87

  • ROCE (%)

    14.97

Score Board

  • Equity (₹ in Cr.)

    91.27

  • BV (₹)

    153.90

  • Sales( ₹ in Cr.)

    2,260.39

  • NP (in Cr.)

    169.22

  • NP Var(%)

    8.0

  • Div%

    20.0

  • CPS (₹)

    24.60

  • EPS (₹)

    18.50

  • Traded Value (₹ in Lakhs)

    3,806.42

  • 52 Week High

    534.55

  • 52 Week Low

    318.95

  • Price BSE

    417.0

  • Price NSE

    416.00

  • Market Capital( in Cr.)

    3,806.42

  • P/C Ratio

    16.90

  • P/E Ratio

    22.50

  • Price Vs.BV

    18.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 2,173.65 2,266.91 2,497.97 2,251.17 1,914.89 1,634.92
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,173.65 2,266.91 2,497.97 2,251.17 1,914.89 1,634.92
Other Income 13.57 4.18 2.23 4.77 9.69 9.44
Stock Adjustments -22.00 -26.77 6.72 77.94 9.08 53.94
Total Income 2,165.22 2,244.32 2,506.92 2,333.88 1,933.66 1,698.30
EXPENDITURE :            
Raw Materials 1,376.63 1,476.42 1,723.25 1,558.47 1,148.99 1,099.82
Power and Fuel Cost 149.05 151.64 153.45 126.05 95.64 101.04
Employee Cost 73.88 70.20 64.30 57.17 55.60 52.65
Other Manufacturing Expenses 203.72 201.92 182.71 171.26 138.99 122.62
Selling and Administration Expenses 74.83 63.27 89.25 89.75 76.70 59.39
Miscellaneous Expenses 8.37 7.52 5.68 5.24 6.72 5.40
Employee Benefit Expenses 73.88 70.20 64.30 57.17 55.60 52.65
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,886.48 1,970.96 2,218.64 2,007.95 1,522.64 1,440.92
Operating Profit 278.74 273.36 288.28 325.94 411.02 257.38
Interest 32.20 33.21 36.18 23.05 25.71 35.74
Gross Profit 246.54 240.15 252.10 302.89 385.31 221.64
Depreciation 47.79 47.67 47.29 47.39 47.60 46.67
Profit Before Tax 198.75 192.48 204.81 255.50 337.71 174.97
Current Tax 37.94 49.60 53.25 65.50 84.50 49.55
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.50 1.00 -1.25 -5.00 -4.50 -10.25
Reported Net Profit 157.31 141.88 152.81 195.00 257.71 135.67
Extraordinary Items 0.00 0.00 0.00 0.00 0.17 6.35
Adjusted Net Profit 157.31 141.88 152.81 195.00 257.54 129.32
Adjustment below Net Profit -58.28 -13.32 0.00 -51.64 -69.90 -26.90
P & L Balance brought forward 1,052.31 947.13 818.86 704.26 565.52 475.07
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 24.86 23.38 24.54 28.76 49.07 18.32
P & L Balance carried down 1,126.48 1,052.31 947.13 818.86 704.26 565.52
Dividend 9.13 9.19 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 10.00 10.00 25.00 20.00
Dividend Per Share(Rs) 1.00 1.00 1.00 1.00 2.50 2.00
Earnings Per Share-Unit Curr 17.24 15.43 16.50 21.06 27.65 58.23
Earnings Per Share(Adj)-Unit Curr 17.24 15.43 16.50 21.06 27.65 14.56
Book Value 137.10 127.83 120.34 104.99 92.23 266.86
Book Value(Adj)-Unit Curr 137.10 127.83 120.34 104.99 92.23 66.72

Shareholding Pattern

  • Promoter Group

    54.43%

  • Public Share Holding

    45.57%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 8,671,669 9.50 8,671,669 7
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 38,118,254 41.76 38,118,254 28
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 2,891,305 3.17 2,891,305 6
Others 0 0.00 0 0
Sub Total 49,681,228 54.43 49,681,228 41
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 16 0.00 16 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,391,378 1.52 1,391,378 55
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 70,214 0.08 70,214 1
Mutual Funds / UTI 9,204,490 10.08 9,204,490 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 120,334 0.13 120,334 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 10,786,432 11.82 10,786,432 68
2] Non Institution
Bodies Corporate 995,602 1.09 995,601 370
Clearing Members 14,167 0.02 14,167 20
Directors of their Relatives 4,952,436 5.43 4,950,611 7
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 806,411 0.88 806,411 2,207
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 724,050 0.79 724,050 3,066
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,907,185 5.38 4,875,185 71
Individuals holding nominal share capital up to Rs. 1 lakh 17,110,124 18.75 16,584,435 137,564
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1 0.00 1 1
Others 1,003,121 1.10 1,003,121 5
Sub Total 30,802,340 33.75 30,242,825 143,367
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 91,270,000 100.00 90,710,485 143,476

Company Background

Aarti Drugs LtdPharmaceuticals - Indian - Bulk Drugs

  • Aarti Drugs Ltd
  • BSE Code : 2975.0
  • ISIN : INE767A01016

  • Incorporation Year

    1984

  • Registered Office

    Plot No N-198 MIDC Tarapur
    Pamtembhi Village Palghar Tal, Thane,
    Maharashtra-401506

  • Telephone

    91-22-24072249

  • FAX

    91-22-24073462/24070144

  • Chairman

    Chandrakant V. Gogri

  • Managing Director

  • Company Secretary

    Rushikesh V Deole

  • Auditor

    Gokhale & Sathe

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Aarti Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aarti Drugs 417.05 2,187.23 2,173.65 22.21 13.49
Abbott India 27,076.90 7,217.19 6,929.05 35.63 43.78
Astrazeneca Phar 7,753.70 2,304.07 2,275.58 114.28 27.86
Glaxosmi. Pharma 2,689.10 3,932.76 3,790.20 42.96 58.17
Novartis India 1,586.70 398.23 356.27 40.07 16.64
Cipla 1,450.00 20,102.60 18,979.95 38.11 13.88
Bliss GVS Pharma 524.05 773.53 729.81 48.66 12.51
Amrutanjan Healt 494.75 469.50 451.82 26.50 21.89
Fermenta Biotec. 449.40 474.15 450.25 20.98 18.77
Guj. Themis Bio. 349.05 152.47 150.80 78.09 27.21
Ambalal Sarabhai 42.47 19.52 3.94 78.65 6.77